Author

N. Q. Zhao

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 6

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 6 Research Focus:cell type annotation· 5 Approach:experimental assay· 5 Research Focus:differential expression· 3 Assay:flow cytometry· 3 Research Focus:host-pathogen & immune response· 3 Research Focus:cell signaling & trafficking· 2 Assay:proteomics· 2

Frequent Co-Authors

C. A. Blish· 6 shared S. Holmes· 3 shared T. Ranganath· 3 shared A. J. Rogers· 2 shared A. J. Wilk· 2 shared A.-M. Ferreira· 2 shared C. Seiler· 2 shared E. Vendrame· 2 shared

Activity by Year

2019-2020 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

6 shared papersImmunology

C. A. Blish

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19

A. J. Wilk, M. J. Lee, B. Wei, B. Parks, R. Pi, G. J. Martinez-Colon, T. Ranganath, N. Q. Zhao, S. Taylor, W. Becker, Stanford COVID-19 Biobank, D. Jimenez-Morales, A. L. Blomkalns, R. O'Hara, E. A. Ashley, , C. A. Blish

Single-cell multi-omic profiling identifies immune dysregulation in severe COVID-19, including neutrophil hyperactivation and anti-inflammatory monocytes.

bioRxiv · Dec 18, 2020Immunology

Additional analyses exploring the hypothesized transdifferentiation of plasmablasts to developing neutrophils in severe COVID-19

A. J. Wilk, A. Rustagi, N. Q. Zhao, B. A. Martin, A. J. Rogers, C. A. Blish

The paper responds to criticisms of a previous study on transdifferentiation of plasmablasts to neutrophils in severe COVID-19 using single-cell transcriptomic data.

bioRxiv · Oct 15, 2020 · PreprintImmunology

Treated HIV Infection Alters Phenotype But Not HIV-specific Function of Peripheral Blood Natural Killer Cells

N. Q. Zhao, A.-M. Ferreira, P. M. Grant, S. Holmes, C. A. Blish

This study examines how treated HIV infection affects NK cell phenotype and function, finding altered repertoires but no increased HIV-specificity.

bioRxiv · Apr 12, 2020Immunology

Characterization of the impact of daclizumab beta on circulating natural killer cells by mass cytometry

T. Ranganath, L. J. Simpson, C. Seiler, A.-M. Ferreira, E. Vendrame, N. Q. Zhao, J. D. Fontenot, S. P. Holmes, C. A. Blish

This study uses mass cytometry to analyze how daclizumab beta affects NK cell phenotypes in RMS patients, showing distinct changes in CD56bright and CD56dim subsets.

bioRxiv · Dec 5, 2019Immunology

TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells

E. Vendrame, C. Seiler, T. Ranganath, N. Q. Zhao, R. Vergara, M. Alary, A. C. Labbe, F. Guedou, J. Poudrier, S. Holmes, M. Roger, C. A. Blish

This study shows that TIGIT is upregulated on NK cells in untreated HIV+ individuals and marks a functional, mature NK cell subset with enhanced responses to HIV-infected targets.

bioRxiv · Sep 10, 2019Immunology

Enhancing natural killer cell function with gp41-targeting bispecific antibodies to combat HIV infection

N. S. Ramadoss, N. Q. Zhao, B. A. Richardson, P. M. Grant, P. S. Kim, C. A. Blish

This study develops bispecific antibodies targeting HIV gp41 and NK cell CD16 to enhance ADCC against HIV-infected cells, showing improved degranulation and killing of infected targets.

bioRxiv · Sep 8, 2019Immunology